(Nanowerk News) A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, No. 21 (Oct. 15, 1996), pp. 11307-11312 (6 pages) Herpes simplex virus vectors are being developed for ...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific gene-integration system, presented at the Cold ...